Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 161 - 180 of 449 trials
Title Investigatorsort icon Disease(s)
A Phase IB/II Study of OMP-59R5 with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer
[Protocol 12-234]
O'Reilly, Eileen
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase I Study of WT1-Specific T Cells for the Treatment of Patients with Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancers
[Protocol 06-155]
O'Cearbhaill, Roisin
  • Ovarian Cancer
Standard Infusion Carboplatin versus Prophylactic Extended Infusion Carboplatin in the Treatment of Patients with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
[Protocol 10-184]
O'Cearbhaill, Roisin
  • Ovarian Cancer
A Study of Bortezomib plus (R)ICE in Subjects with Relapsed/Refractory AIDS-Associated Non-Hodgkin's Lymphoma
[Protocol 09-063]
Noy, Ariela
  • AIDS-Associated Cancers
    • AIDS-Associated Lymphomas
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I/II Study of EPOCH Chemotherapy, Bortezomib, and Raltegravir for the Treatment of HTLV-1-Associated T-Cell Leukemia/Lymphoma
[Protocol 12-146]
Noy, Ariela
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I/II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin's Lymphoma
[Protocol 11-013]
Noy, Ariela
  • AIDS-Associated Cancers
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Dose-Adjusted EPOCH Chemotherapy with or without Rituximab in Patients with Untreated Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma, or Plasmablastic Lymphoma
[Protocol 13-022]
Noy, Ariela
  • Lymphoma
    • Non-Hodgkin's Lymphoma
High-Dose Chemotherapy with Autologous Stem Cell Rescue for Aggressive B-Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients
[Protocol 10-181]
Noy, Ariela
  • AIDS-Associated Cancers
    • AIDS-Associated Lymphomas
  • Blood & Marrow Stem Cell Transplantation
    • Autologous
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
Prostate Cancer Treatment Decision-Making and Survivorship
[Protocol 11-058]
Nelson, Christian
  • Prostate Cancer
    • Localized Disease
    • Quality of Life
  • Survivorship
The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men with Prostate Cancer Age 65 and Older
[Protocol 06-084]
Nelson, Christian
  • Geriatrics
  • Prostate Cancer
    • Localized Disease
    • Quality of Life
    • Rising PSA After Primary Therapy
  • Psychiatry & Behavioral Sciences
  • Survivorship
ICARuS (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Phase II Study of Early Post-Operative Abdominal Chemotherapy versus Heated Abdominal Chemotherapy for Cancers of the Appendix, Colon, or Rectum that Have Spread to the Abdominal Lining
[Protocol 12-289]
Nash, Garrett
  • Colorectal Cancer
A Randomized Trial of Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy
[Protocol 09-005]
Mulhall, John
  • Prostate Cancer
    • Quality of Life
  • Survivorship
A Phase II Study of Everolimus as Second-Line Therapy in the Treatment of Metastatic Renal Cell Carcinoma
[Protocol 11-197]
Motzer, Robert
  • Kidney Cancer
A Phase III Study of BMS-936558 Versus Everolimus in Patients with Advanced or Metastatic Renal Cell Carcinoma Who Received Prior Anti-Angiogenic Therapy
[Protocol 12-159]
Motzer, Robert
  • Kidney Cancer
A Phase III Study of Pazopanib as Adjuvant Therapy for Patients with Localized or Locally Advanced Renal Cell Carcinoma Following Nephrectomy
[Protocol 10-162]
Motzer, Robert
  • Kidney Cancer
A Phase I Study of SGN-CD19A in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
[Protocol 12-282]
Moskowitz, Craig
  • Lymphoma
    • Non-Hodgkin's Lymphoma
Risk-Adapted Therapy for Patients With Untreated Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B-Cell Lymphoma
[Protocol 08-026]
Moskowitz, Craig
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of KW-0761 versus Vorinostat in Patients with Previously Treated Cutaneous T-Cell Lymphoma
[Protocol 13-007]
Moskowitz, Alison
  • Lymphoma
    • Non-Hodgkin's Lymphoma
Brentuximab (SGN-35) in Transplant-Eligible Patients with Relapsed or Refractory Hodgkin Lymphoma
[Protocol 11-142]
Moskowitz, Alison
  • Lymphoma
    • Hodgkin's Disease
Radium-223 (Alpharadin) in Men with Castration-Resistant Prostate Cancer and Bone Metastases
[Protocol 12-199]
Morris, Michael
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy